Physician profile
Karen L Frederick
NPI 1649593112
$1,423.13
in general payments reported to CMS, 2019-2025
17 companies · $237 in 2025
The $237 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $132 · 2022: $415 · 2023: $263 · 2024: $377 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $876.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $876.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $526.96 | 2021-2025 | |
| Novo Nordisk INC | $211.97 | 2021-2023 | Ozempic, Rybelsus |
| Pfizer INC. | $108.05 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $96.23 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $79.86 | 2022-2023 | Jardiance |
| Axsome Therapeutics, INC. | $76.82 | 2025 | Auvelity |
| Corcept Therapeutics | $73.41 | 2023-2024 | Korlym |
| Lilly USA, LLC | $42.16 | 2025 | Zepbound, Mounjaro |
| Dexcom, INC. | $40.93 | 2023-2025 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $32.73 | 2021-2025 | Breztri |
| Cranial Technologies, INC | $32.38 | 2022-2023 | Doc Band |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.98 | 2023 | Xifaxan |
| Otsuka America Pharmaceutical, INC. | $19.05 | 2022 | |
| Nevro Corp. | $16.84 | 2022 | |
| Daiichi Sankyo INC. | $14.96 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $14.01 | 2021 | |
| Coopersurgical, INC. | $13.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Frederick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.